Compounded (Rx)IV / SubQ / Inhaled · Antioxidant

Glutathione

GSH — Master Antioxidant Tripeptide

Half-life
~10 min (IV plasma); cellular activity much longer
Route
IV, SubQ, or inhaled
Typical dose
600–1200 mg IV; 200–400 mg SubQ
Reconstitutable
Yes — lyophilized

What is Glutathione?

Glutathione (GSH) is the most abundant intracellular antioxidant in the human body — a tripeptide (glutamate-cysteine-glycine) present in virtually every cell. It neutralizes free radicals, regenerates vitamins C and E, supports detoxification in the liver, and regulates immune function. Glutathione levels decline with age, chronic illness, poor diet, and environmental toxin exposure. Injectable glutathione bypasses the poor oral bioavailability of oral glutathione supplements.

Glutathione neutralizes reactive oxygen species (ROS) through the GSH/GSSG redox cycle, with glutathione peroxidase and reductase enzymes recycling oxidized glutathione (GSSG) back to reduced form (GSH). In the liver, GSH conjugates toxins for excretion via the glutathione S-transferase system. It also directly modulates immune cell function and supports mitochondrial integrity. Injectable delivery bypasses the gut where oral glutathione is largely degraded before absorption.

Research Evidence

SilverLiver Detoxification

IV glutathione is established in clinical hepatology for liver protection in acetaminophen overdose and other hepatotoxic conditions. Strong mechanistic basis for liver support.

SilverSkin Lightening

IV glutathione for skin lightening is widely practiced in Asia and the Philippines. Inhibits melanin synthesis through tyrosinase inhibition. Multiple clinical studies confirm efficacy.

BronzeAnti-aging & General Antioxidant

Community use for energy, immune support, and anti-aging is widespread. IV glutathione produces rapid NAD+-like energy effects anecdotally. Controlled longevity data is limited.

Evidence grades: Gold = RCT human data · Silver = consistent animal/human data · Bronze = limited or preliminary

Dosing Protocols

IV dose
600–1200 mg in 50-100ml saline
Administered over 15-30 minutes. Often combined with vitamin C IV for enhanced antioxidant effect.
SubQ dose
200–400 mg/day
Subcutaneous injection for home use. More practical than IV for regular maintenance.
Frequency
2-3x weekly (IV); daily (SubQ)
IV protocols often 2-3x weekly for 4-8 weeks, then monthly maintenance. SubQ can be daily.

Reconstitution / Preparation

Vial/PackDiluentConcentrationTypical draw
600 mg6 ml sterile water100 mg/ml200mg SubQ = 200 units
1200 mg10 ml sterile water120 mg/ml400mg SubQ = 33 units
Open Reconstitution Calculator →

Frequently Asked Questions

Why not just take oral glutathione supplements?

Oral glutathione is largely degraded in the GI tract before it can be absorbed intact. The amino acids (glutamate, cysteine, glycine) are absorbed and cells rebuild glutathione from precursors, but peak glutathione elevation is much lower than IV. Liposomal oral glutathione improves absorption but still does not match IV levels. For therapeutic glutathione elevation, injectable delivery is significantly more effective.

Can glutathione be mixed with vitamin C in the same syringe?

No — glutathione and vitamin C oxidize each other rapidly when mixed. They should be administered separately. When done IV, vitamin C is typically given first, followed by a saline flush, then glutathione. SubQ injections should be separate.

References

  1. [1]Schmitt B, Vicenzi M, Garrel C, Denis FM. Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers. Redox Biol. 2015;6:198-205.
  2. [2]Weschawalit S, Thongthip S, Phutrakool P, Asawanonda P. Glutathione and its antiaging and antimelanogenic effects. Clin Cosmet Investig Dermatol. 2017;10:147-153.
Disclaimer: This profile is for informational and research purposes only. Not medical advice. Always consult a licensed healthcare provider before using any compound.

This profile was prepared using AI-assisted research synthesis. Citations are provided where applicable — verify with primary sources before clinical application.

Share this article